Does ruxolitinib really prolong survival in individuals with myelofibrosis? The never-ending story
Giovanni Barosi, Robert Peter Gale
Topics & Concepts
RuxolitinibMyelofibrosisMedicineInternal medicineOncologyBone marrowMyeloproliferative Neoplasms: Diagnosis and TreatmentEosinophilic Disorders and SyndromesKruppel-like factors research